Background: Taking into consideration the known overexpression of p16(INK4a) in histologically demonstrated high-grade urothelial malignancies, the objective of the current study was to examine the value of p16(INK4a) overexpression and of p16/Ki-67 dual labeling versus urinary cytology in the detection of urothelial lesions.

Methods: Immunolabeling was performed on demounted and destained Papanicolaou slides after liquid-based ThinPrep processing. Actual diagnoses were ascertained by cystoscopy controls and histopathology. Negative cases, papillary urothelial neoplasia of low malignant potential/low-grade tumor, and high-grade lesions were considered separately.

Results: A total of 216 urine samples were collected from new patients with symptoms who were referred for cystoscopy (92 cases) or patients who were being followed after conservative treatment for lesions involving the bladder (117 cases) or the upper urinary tract (7 cases). p16(INK4a) positivity was assessed in 171 of the 216 cases (79.2%) and in 93 of 99 high-grade cases with positive cytology (93.9%). Coexpression of p16/Ki-67 in the same cells was observed in 119 of 216 cases (55.1%) and was noted in 18 of 51 cases of negative or papillary urothelial neoplasia of low malignant potential/low-grade tumor (35.3%) and in 80 of 101 high-grade tumors (79.2%) (P < .0001). Thirteen of 14 high-grade intraurothelial lesions (92.8%) were dual labeled. When high-grade tumors, disease progression (increased grade, muscle infiltration, and extension into the upper urinary tract), and cancer-related death were grouped together as an endpoint, dual labeling demonstrated a sensitivity that was slightly higher than that of urinary cytology (82.5% vs 80.8%; P = .8), with 94.9% overall specificity.

Conclusions: When applied to the search for high-grade and aggressive disease, p16/Ki-67 dual labeling and urinary cytology appear to demonstrate comparable performance.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.21376DOI Listing

Publication Analysis

Top Keywords

dual labeling
16
urinary cytology
16
p16/ki-67 dual
12
overexpression p16/ki-67
8
labeling versus
8
cases
8
papillary urothelial
8
urothelial neoplasia
8
neoplasia low
8
low malignant
8

Similar Publications

Background: Ochratoxin A (OTA) is toxic secondary metabolites produced by fungi and can pose a serious threat to food safety and human health. Due to the high stability and toxicity, OTA contamination in agricultural products is of great concern. Therefore, the development of a highly sensitive and reliable OTA detection method is crucial to ensure food safety.

View Article and Find Full Text PDF

Marine pollution due to oil spills presents major risks to coastal areas and aquatic life, leading to serious environmental health concerns. Oil Spill detection using SAR data has transitioned from traditional segmentation to a variety of machine learning & deep learning models like UNET proving its efficiency for the task. This research paper proposes a GSCAT-UNET model for efficient oil spill detection and discrimination from lookalikes.

View Article and Find Full Text PDF

Background: Overexpression of interleukin (IL)-17A and IL-17F significantly influences psoriasis pathology. Until recently, biologics targeting IL-17A alone, like secukinumab, were used to treat psoriasis. Bimekizumab is a monoclonal IgG1 antibody that targets both IL-17A and IL-17F.

View Article and Find Full Text PDF

To improve the performance of Radio Frequency Identification (RFID) multi-label systems, the multi-label network structure needs to be quickly located and optimized. A multi-label location measurement method based on the NLM-Harris algorithm is proposed in this paper. Firstly, multi-label geometric distribution images are obtained through a label image acquisition system of a multi-label semi-physical simulation platform with two vertical Charge-Coupled Device (CCD) cameras, and Gaussian noise is added to the image to simulate thermoelectric interference.

View Article and Find Full Text PDF

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent inflammation, joint pain, and progressive cartilage and bone erosion. Despite advancements in RA management with disease-modifying antirheumatic drugs (DMARDs) and biologics, some patients remain refractory to conventional treatments. Tetracyclines, such as minocycline and doxycycline, exhibit anti-inflammatory and immunomodulatory properties, making them potential supplementary treatments.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!